Aggressive treatment of patients with metastatic colorectal cancer increases survival: a scandinavian single-center experience.

Conclusion. Our data support that one still, and perhaps to an even greater extent, should seek an aggressive therapeutic strategy to achieve resectable status for recurrent hepatic and extrahepatic metastases. The data should be viewed in the context of recent advances in the understanding of cancer biology and the metastatic process. PMID: 23840074 [PubMed]
Source: HPB Surgery - Category: Surgery Tags: HPB Surg Source Type: research